Provided by Tiger Fintech (Singapore) Pte. Ltd.

Marinus Pharmaceuticals

0.5500
+0.0000
Volume:- -
Turnover:605.61K
Market Cap:30.35M
PE:-0.22
High:0.5500
Open:0.5500
Low:0.5500
Close:0.5500
Loading ...

Marinus Pharmaceuticals Inc - Engages Barclays to Evaluate Strategic Alternatives

THOMSON REUTERS
·
24 Oct 2024

BRIEF-Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 Raise Trial In Refractory Status Epilepticus At The Neurocritical Care Society 2024 Annual Meeting

Reuters
·
17 Oct 2024

Marinus Pharmaceuticals presents clinical data from pivotal phase 3 RAISE trial

TIPRANKS
·
17 Oct 2024

Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 Raise Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting

THOMSON REUTERS
·
17 Oct 2024

Marinus Pharmaceuticals Gets New US Patent for Ztalmy Titration Regimens; Shares Rise After Hours

MT Newswires Live
·
16 Oct 2024

Longboard Deal Seen Positive for Other DEE Players -- Market Talk

Dow Jones
·
14 Oct 2024

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
09 Oct 2024

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Business Wire
·
09 Oct 2024

Here’s Why PGIM Jennison Health Sciences Fund Reduced its Position in Marinus Pharmaceuticals (MRNS)

Insider Monkey
·
03 Oct 2024

Marinus Pharmaceuticals Initiated at Buy by EF Hutton

Dow Jones
·
01 Oct 2024

Great week for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) institutional investors after losing 78% over the previous year

Simply Wall St.
·
26 Sep 2024

Marinus Pharmaceuticals Price Target Maintained With a $10.00/Share by JMP Securities

Dow Jones
·
23 Sep 2024

TD Cowen Reaffirms Their Buy Rating on Marinus (MRNS)

TIPRANKS
·
23 Sep 2024

Truist Financial Reaffirms Their Buy Rating on Marinus (MRNS)

TIPRANKS
·
23 Sep 2024

Oppenheimer Upgrades Marinus Pharmaceuticals to Outperform From Perform

MT Newswires Live
·
23 Sep 2024

Marinus Pharmaceuticals: A Strong Buy on Promising TSC Treatment Prospects and High Success Probability

TIPRANKS
·
23 Sep 2024